{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:28:35Z","timestamp":1791919715359,"version":"4.3.4"},"reference-count":187,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T00:00:00Z","timestamp":1692576000000},"content-version":"vor","delay-in-days":2150,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS003130"],"award-info":[{"award-number":["NS003130"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s13311-017-0575-2","type":"journal-article","created":{"date-parts":[[2017,9,26]],"date-time":"2017-09-26T13:12:09Z","timestamp":1506431529000},"page":"1027-1048","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Therapeutic Approaches for Zika Virus Infection of the Nervous System"],"prefix":"10.1016","volume":"14","author":[{"given":"Rachel P.M.","family":"Abrams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Solis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avindra","family":"Nath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1007\/s13311-017-0575-2_bib1","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0035-9203(52)90042-4","article-title":"Zika virus (I). Isolations and serological specificity","volume":"46","author":"Dick","year":"1952","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"3","key":"10.1007\/s13311-017-0575-2_bib2","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0035-9203(81)90100-0","article-title":"Zika virus, a cause of fever in Central Java, Indonesia","volume":"75","author":"Olson","year":"1981","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"8","key":"10.1007\/s13311-017-0575-2_bib3","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.3201\/eid1408.080287","article-title":"Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007","volume":"14","author":"Lanciotti","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"10.1007\/s13311-017-0575-2_bib4","doi-asserted-by":"crossref","DOI":"10.1093\/aje\/kwx008","article-title":"Real-time assessment of health-care requirements during the Zika virus epidemic in Martinique","author":"Andronico","year":"2017","journal-title":"Am J Epidemiol"},{"issue":"10027","key":"10.1007\/s13311-017-0575-2_bib5","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S0140-6736(16)00562-6","article-title":"Guillain-Barr\u00e9 Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study","volume":"387","author":"Cao-Lormeau","year":"2016","journal-title":"Lancet"},{"issue":"7","key":"10.1007\/s13311-017-0575-2_bib6","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1056\/NEJMp1600297","article-title":"Zika virus in the Americas\u2014yet another arbovirus threat","volume":"374","author":"Fauci","year":"2016","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1007\/s13311-017-0575-2_bib7","first-page":"334","article-title":"WHO Director-General summarizes the outcome of the Emergency Committee regarding clusters of microcephaly and Guillain-Barr\u00e9 syndrome","volume":"37","author":"Organization WH","year":"2016","journal-title":"Saudi Med J"},{"issue":"1","key":"10.1007\/s13311-017-0575-2_bib8","doi-asserted-by":"crossref","first-page":"e00055","DOI":"10.1128\/MMBR.00055-16","article-title":"The antigenic structure of Zika virus and its relation to other flaviviruses: implications for infection and immunoprophylaxis","volume":"81","author":"Heinz","year":"2017","journal-title":"Microbiol Mol Biol Rev"},{"issue":"4","key":"10.1007\/s13311-017-0575-2_bib9","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00705-006-0903-z","article-title":"Full-length sequencing and genomic characterization of Bagaza, Kedougou, and Zika viruses","volume":"152","author":"Kuno","year":"2007","journal-title":"Arch Virol"},{"issue":"2","key":"10.1007\/s13311-017-0575-2_bib10","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1099\/jgv.0.000381","article-title":"Zika virus: a previously slow pandemic spreads rapidly through the Americas","volume":"97","author":"Gatherer","year":"2016","journal-title":"J Gen Virol"},{"issue":"2","key":"10.1007\/s13311-017-0575-2_bib11","first-page":"86","article-title":"Zika Virus: a re-emerging pathogen with rapidly evolving public health implications","volume":"39","author":"Turrini","year":"2016","journal-title":"New Microbiol"},{"issue":"5","key":"10.1007\/s13311-017-0575-2_bib12","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.chom.2016.04.013","article-title":"Structures of the Zika virus envelope protein and its complex with a flavivirus broadly protective antibody","volume":"19","author":"Dai","year":"2016","journal-title":"Cell Host Microbe"},{"issue":"6284","key":"10.1007\/s13311-017-0575-2_bib13","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1126\/science.aaf5316","article-title":"The 3.8 \u00c5 resolution cryo-EM structure of Zika virus","volume":"352","author":"Sirohi","year":"2016","journal-title":"Science"},{"issue":"7603","key":"10.1007\/s13311-017-0575-2_bib14","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nature17994","article-title":"Structure of the thermally stable Zika virus","volume":"533","author":"Kostyuchenko","year":"2016","journal-title":"Nature"},{"issue":"1","key":"10.1007\/s13311-017-0575-2_bib15","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3390\/v6010069","article-title":"Flavivirus entry receptors: an update","volume":"6","author":"Perera-Lecoin","year":"2013","journal-title":"Viruses"},{"issue":"2","key":"10.1007\/s13311-017-0575-2_bib16","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3390\/v3020160","article-title":"Flavivirus cell entry and membrane fusion","volume":"3","author":"Smit","year":"2011","journal-title":"Viruses"},{"issue":"9","key":"10.1007\/s13311-017-0575-2_bib17","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nrmicro1928","article-title":"Architects of assembly: roles of Flaviviridae non-structural proteins in virion morphogenesis","volume":"6","author":"Murray","year":"2008","journal-title":"Nat Rev Microbiol"},{"issue":"6298","key":"10.1007\/s13311-017-0575-2_bib18","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1126\/science.aag2419","article-title":"Crystal structure of Zika virus NS2B-NS3 protease in complex with a boronate inhibitor","volume":"353","author":"Lei","year":"2016","journal-title":"Science"},{"issue":"20","key":"10.1007\/s13311-017-0575-2_bib19","doi-asserted-by":"crossref","first-page":"10438","DOI":"10.1128\/JVI.00986-10","article-title":"The endoplasmic reticulum provides the membrane platform for biogenesis of the flavivirus replication complex","volume":"84","author":"Gillespie","year":"2010","journal-title":"J Virol"},{"issue":"1","key":"10.1007\/s13311-017-0575-2_bib20","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1128\/JVI.02085-14","article-title":"Perturbation in the conserved methyltransferase-polymerase interface of flavivirus NS5 differentially affects polymerase initiation and elongation","volume":"89","author":"Wu","year":"2015","journal-title":"J Virol"},{"issue":"4","key":"10.1007\/s13311-017-0575-2_bib21","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.chom.2009.03.007","article-title":"Composition and three-dimensional architecture of the dengue virus replication and assembly sites","volume":"5","author":"Welsch","year":"2009","journal-title":"Cell Host Microbe"},{"issue":"23","key":"10.1007\/s13311-017-0575-2_bib22","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1038\/emboj.2008.232","article-title":"Insights into RNA unwinding and ATP hydrolysis by the flavivirus NS3 protein","volume":"27","author":"Luo","year":"2008","journal-title":"EMBO J"},{"issue":"5871","key":"10.1007\/s13311-017-0575-2_bib23","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1126\/science.1153264","article-title":"Structure of the immature dengue virus at low pH primes proteolytic maturation","volume":"319","author":"Yu","year":"2008","journal-title":"Science"},{"issue":"5","key":"10.1007\/s13311-017-0575-2_bib24","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0092-8674(02)00660-8","article-title":"Structure of dengue virus: implications for flavivirus organization, maturation, and fusion","volume":"108","author":"Kuhn","year":"2002","journal-title":"Cell"},{"key":"10.1007\/s13311-017-0575-2_bib25","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.antiviral.2009.09.007","article-title":"In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses","volume":"84","author":"Kampmann","year":"2009","journal-title":"Antiviral Res"},{"issue":"11","key":"10.1007\/s13311-017-0575-2_bib26","doi-asserted-by":"crossref","first-page":"8475","DOI":"10.1128\/jvi.71.11.8475-8481.1997","article-title":"Proteolytic activation of tick-borne encephalitis virus by furin","volume":"71","author":"Stadler","year":"1997","journal-title":"J Virol"},{"issue":"3","key":"10.1007\/s13311-017-0575-2_bib27","doi-asserted-by":"crossref","first-page":"411","DOI":"10.4269\/ajtmh.1969.18.411","article-title":"Isolation of Zika virus from Aedes aegypti mosquitoes in Malaysia","volume":"18","author":"Marchette","year":"1969","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"10.1007\/s13311-017-0575-2_bib28","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3201\/eid2101.140894","article-title":"Detection of Zika virus in urine","volume":"21","author":"Gourinat","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"10.1007\/s13311-017-0575-2_bib29","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jcv.2015.04.021","article-title":"Detection of Zika virus in saliva","volume":"68","author":"Musso","year":"2015","journal-title":"J Clin Virol"},{"issue":"10023","key":"10.1007\/s13311-017-0575-2_bib30","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S0140-6736(16)00624-3","article-title":"Infectious Zika viral particles in breastmilk","volume":"387","author":"Dupont-Rouzeyrol","year":"2016","journal-title":"Lancet"},{"issue":"9","key":"10.1007\/s13311-017-0575-2_bib31","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S1473-3099(16)30193-1","article-title":"Zika virus in the female genital tract","volume":"16","author":"Prisant","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1007\/s13311-017-0575-2_bib32","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S1473-3099(16)00138-9","article-title":"Zika virus: high infectious viral load in semen, a new sexually transmitted pathogen","volume":"16","author":"Mansuy","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"23","key":"10.1007\/s13311-017-0575-2_bib33","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2016.21.23.30254","article-title":"Sexual transmission of Zika virus in an entirely asymptomatic couple returning from a Zika epidemic area, France, April 2016","volume":"21","author":"Fr\u00e9our","year":"2016","journal-title":"Eurosurveillance"},{"key":"10.1007\/s13311-017-0575-2_bib34","doi-asserted-by":"crossref","unstructured":"Davidson A. Suspected female-to-male sexual transmission of Zika virus\u2014New York City, 2016. MMWR Morb Mortal Wkly Rep 2016;65.","DOI":"10.15585\/mmwr.mm6528e2"},{"issue":"13","key":"10.1007\/s13311-017-0575-2_bib35","doi-asserted-by":"crossref","first-page":"20751","DOI":"10.2807\/1560-7917.ES2014.19.13.20751","article-title":"Evidence of perinatal transmission of Zika virus, French Polynesia, December 2013 and February 2014","volume":"19","author":"Besnard","year":"2014","journal-title":"Euro Surveill"},{"issue":"14","key":"10.1007\/s13311-017-0575-2_bib36","doi-asserted-by":"crossref","first-page":"20761","DOI":"10.2807\/1560-7917.ES2014.19.14.20761","article-title":"Potential for Zika virus transmission through blood transfusion demonstrated during an outbreak in French Polynesia, November 2013 to February 2014","volume":"19","author":"Musso","year":"2014","journal-title":"Euro Surveill"},{"issue":"10","key":"10.1007\/s13311-017-0575-2_bib37","doi-asserted-by":"crossref","first-page":"689","DOI":"10.7326\/M16-0332","article-title":"Emergence of congenital Zika syndrome: viewpoint from the front lines: emergence of congenital Zika syndrome","volume":"164","author":"Costa","year":"2016","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1007\/s13311-017-0575-2_bib38","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0035-9203(54)90006-1","article-title":"Zika virus: a report on three cases of human infection during an epidemic of jaundice in Nigeria","volume":"48","author":"Macnamara","year":"1954","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1007\/s13311-017-0575-2_bib39","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jcv.2014.12.005","article-title":"Zika virus infections imported to Italy: clinical, immunological and virological findings, and public health implications","volume":"63","author":"Zammarchi","year":"2015","journal-title":"J Clin Virol"},{"issue":"360","key":"10.1007\/s13311-017-0575-2_bib40","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1056\/NEJMoa0805715","article-title":"Zika virus outbreak on Yap Island, federated states of Micronesia","volume":"2009","author":"Duffy","year":"2009","journal-title":"N Engl J Med"},{"issue":"9611","key":"10.1007\/s13311-017-0575-2_bib41","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0140-6736(08)60238-X","article-title":"Pathogenic flaviviruses","volume":"371","author":"Gould","year":"2008","journal-title":"Lancet"},{"issue":"16","key":"10.1007\/s13311-017-0575-2_bib42","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2016.21.16.30205","article-title":"Zika virus detection in cerebrospinal fluid from two patients with encephalopathy, Martinique, February 2016","volume":"21","author":"Roz\u00e9","year":"2016","journal-title":"Euro Surveill"},{"issue":"10026","key":"10.1007\/s13311-017-0575-2_bib43","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0140-6736(16)00644-9","article-title":"Acute myelitis due to Zika virus infection","volume":"387","author":"M\u00e9charles","year":"2016","journal-title":"Lancet"},{"issue":"10015","key":"10.1007\/s13311-017-0575-2_bib44","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0140-6736(16)00006-4","article-title":"Zika virus in Brazil and macular atrophy in a child with microcephaly","volume":"387","author":"Ventura","year":"2016","journal-title":"Lancet"},{"issue":"10033","key":"10.1007\/s13311-017-0575-2_bib45","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1016\/S0140-6736(16)00742-X","article-title":"Microcephaly and Zika virus infection","volume":"387","author":"Rodrigues","year":"2016","journal-title":"Lancet"},{"issue":"374","key":"10.1007\/s13311-017-0575-2_bib46","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1056\/NEJMoa1600651","article-title":"Zika virus associated with microcephaly","volume":"2016","author":"Mlakar","year":"2016","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1007\/s13311-017-0575-2_bib47","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1212\/WNL.52.3.635","article-title":"Fatal Guillain-Barr\u00e9 syndrome","volume":"52","author":"Lawn","year":"1999","journal-title":"Neurology"},{"issue":"10047","key":"10.1007\/s13311-017-0575-2_bib48","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S0140-6736(16)30883-2","article-title":"Pathology of congenital Zika syndrome in Brazil: a case series","volume":"388","author":"Martines","year":"2016","journal-title":"Lancet"},{"issue":"2","key":"10.1007\/s13311-017-0575-2_bib49","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.immuni.2017.02.005","article-title":"Prospects for a Zika virus vaccine","volume":"46","author":"Barouch","year":"2017","journal-title":"Immunity"},{"key":"10.1007\/s13311-017-0575-2_bib50","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.antiviral.2016.11.023","article-title":"The FDA-approved drug sofosbuvir inhibits Zika virus infection","volume":"137","author":"Bullard-Feibelman","year":"2017","journal-title":"Antiviral Res"},{"issue":"47","key":"10.1007\/s13311-017-0575-2_bib51","doi-asserted-by":"crossref","first-page":"14682","DOI":"10.1073\/pnas.1508095112","article-title":"Virion-associated phosphatidylethanolamine promotes TIM1-mediated infection by Ebola, dengue, and West Nile viruses","volume":"112","author":"Richard","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1007\/s13311-017-0575-2_bib52","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.chom.2016.07.002","article-title":"Zika virus targets different primary human placental cells, suggesting two routes for vertical transmission","volume":"20","author":"Tabata","year":"2016","journal-title":"Cell Host Microbe"},{"issue":"3","key":"10.1007\/s13311-017-0575-2_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003232","article-title":"TIM-family proteins promote infection of multiple enveloped viruses through virion-associated phosphatidylserine","volume":"9","author":"Jemielity","year":"2013","journal-title":"PLOS Pathog"},{"key":"10.1007\/s13311-017-0575-2_bib54","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.celrep.2016.12.068","article-title":"Screening bioactives reveals nanchangmycin as a broad spectrum antiviral active against Zika virus","volume":"18","author":"Rausch","year":"2017","journal-title":"Cell Rep"},{"issue":"12","key":"10.1007\/s13311-017-0575-2_bib55","doi-asserted-by":"crossref","first-page":"6986","DOI":"10.1073\/pnas.0832193100","article-title":"A ligand-binding pocket in the dengue virus envelope glycoprotein","volume":"100","author":"Modis","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6529","key":"10.1007\/s13311-017-0575-2_bib56","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/375291a0","article-title":"The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution","volume":"375","author":"Rey","year":"1995","journal-title":"Nature"},{"issue":"22","key":"10.1007\/s13311-017-0575-2_bib57","doi-asserted-by":"crossref","first-page":"11000","DOI":"10.1128\/JVI.01735-06","article-title":"Crystal structure of West Nile virus envelope glycoprotein reveals viral surface epitopes","volume":"80","author":"Kanai","year":"2006","journal-title":"J Virol"},{"key":"10.1007\/s13311-017-0575-2_bib58","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1128\/AAC.01148-08","article-title":"A small-molecule dengue virus entry inhibitor","volume":"53","author":"Wang","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1007\/s13311-017-0575-2_bib59","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15672","article-title":"A peptide-based viral inactivator inhibits Zika virus infection in pregnant mice and fetuses","volume":"8","author":"Yu","year":"2017","journal-title":"Nat Commun"},{"issue":"3","key":"10.1007\/s13311-017-0575-2_bib60","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.immuni.2017.02.012","article-title":"25-Hydroxycholesterol protects host against Zika virus infection and its associated microcephaly in a mouse model","volume":"46","author":"Li","year":"2017","journal-title":"Immunity"},{"key":"10.1007\/s13311-017-0575-2_bib61","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.antiviral.2015.06.013","article-title":"Suramin inhibits chikungunya virus replication through multiple mechanisms","volume":"121","author":"Albulescu","year":"2015","journal-title":"Antiviral Res"},{"issue":"1","key":"10.1007\/s13311-017-0575-2_bib62","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12985-016-0607-2","article-title":"Suramin is a potent inhibitor of Chikungunya and Ebola virus cell entry","volume":"13","author":"Hen\u00df","year":"2016","journal-title":"Virol J"},{"issue":"7","key":"10.1007\/s13311-017-0575-2_bib63","doi-asserted-by":"crossref","first-page":"e0133511","DOI":"10.1371\/journal.pone.0133511","article-title":"Suramin inhibits chikungunya virus entry and transmission","volume":"10","author":"Ho","year":"2015","journal-title":"PLOS ONE"},{"key":"10.1007\/s13311-017-0575-2_bib64","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.antiviral.2017.04.017","article-title":"Polysulfonate suramin inhibits Zika virus infection","volume":"143","author":"Tan","year":"2017","journal-title":"Antiviral Res"},{"issue":"9","key":"10.1007\/s13311-017-0575-2_bib65","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/nrd2092","article-title":"Targeting proteases: successes, failures and future prospects","volume":"5","author":"Turk","year":"2006","journal-title":"Nat Rev Drug Discov"},{"issue":"9","key":"10.1007\/s13311-017-0575-2_bib66","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/nrd3053","article-title":"Emerging principles in protease-based drug discovery","volume":"9","author":"Drag","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1007\/s13311-017-0575-2_bib67","series-title":"Antiviral strategies. Handbook of experimental pharmacology","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-540-79086-0_4","article-title":"Viral protease inhibitors","author":"Anderson","year":"2009"},{"key":"10.1007\/s13311-017-0575-2_bib68","article-title":"FDA approves 3TC and saquinavir. Food and Drug Administration","volume":"Dec","author":"Baker","year":"1995","journal-title":"BETA"},{"issue":"8","key":"10.1007\/s13311-017-0575-2_bib69","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nrd4050","article-title":"Novel therapies for hepatitis C\u2014one pill fits all?","volume":"12","author":"Manns","year":"2013","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"10.1007\/s13311-017-0575-2_bib70","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nsmb1073","article-title":"Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus","volume":"13","author":"Erbel","year":"2006","journal-title":"Nat Struct Mol Biol"},{"issue":"4","key":"10.1007\/s13311-017-0575-2_bib71","doi-asserted-by":"crossref","first-page":"e00800","DOI":"10.1128\/genomeA.00800-16","article-title":"Complete genome sequences of three historically important, spatiotemporally distinct, and genetically divergent strains of Zika virus: MR-766, P6-740, and PRVABC-59","volume":"4","author":"Yun","year":"2016","journal-title":"Genome Announc"},{"issue":"49","key":"10.1007\/s13311-017-0575-2_bib72","doi-asserted-by":"crossref","first-page":"45762","DOI":"10.1074\/jbc.M107360200","article-title":"Activity of recombinant dengue 2 virus NS3 protease in the presence of a truncated NS2B co-factor, small peptide substrates, and inhibitors","volume":"276","author":"Leung","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1007\/s13311-017-0575-2_bib73","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/cr.2016.116","article-title":"Mechanisms of activation and inhibition of Zika virus NS2B-NS3 protease","volume":"26","author":"Chen","year":"2016","journal-title":"Cell Res"},{"key":"10.1007\/s13311-017-0575-2_bib74","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.antiviral.2016.12.016","article-title":"Identification of novel small molecule inhibitors against NS2B\/NS3 serine protease from Zika virus","volume":"139","author":"Lee","year":"2017","journal-title":"Antiviral Res"},{"issue":"20","key":"10.1007\/s13311-017-0575-2_bib75","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1002\/1873-3468.12443","article-title":"Substrate profiling of Zika virus NS2B\u2010NS3 protease","volume":"590","author":"Gruba","year":"2016","journal-title":"FEBS Lett"},{"key":"10.1007\/s13311-017-0575-2_bib76","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.antiviral.2016.12.018","article-title":"Extended substrate specificity and first potent irreversible inhibitor\/activity-based probe design for Zika virus NS2B-NS3 protease","volume":"139","author":"Rut","year":"2017","journal-title":"Antiviral Res"},{"issue":"11","key":"10.1007\/s13311-017-0575-2_bib77","doi-asserted-by":"crossref","first-page":"e0004058","DOI":"10.1371\/journal.pntd.0004058","article-title":"Proteasome inhibition suppresses dengue virus egress in antibody dependent infection","volume":"9","author":"Choy","year":"2015","journal-title":"PLOS Negl Trop Dis"},{"issue":"2","key":"10.1007\/s13311-017-0575-2_bib78","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.chom.2016.07.004","article-title":"A screen of FDA-approved drugs for inhibitors of Zika virus infection","volume":"20","author":"Barrows","year":"2016","journal-title":"Cell Host Microbe"},{"issue":"11","key":"10.1007\/s13311-017-0575-2_bib79","first-page":"2615","article-title":"Proteasome inhibitors: a novel class of potent and effective antitumor agents","volume":"59","author":"Adams","year":"1999","journal-title":"Cancer Res"},{"issue":"4","key":"10.1007\/s13311-017-0575-2_bib80","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1056\/NEJMoa051379","article-title":"The risk associated with aprotinin in cardiac surgery","volume":"354","author":"Mangano","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1007\/s13311-017-0575-2_bib81","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.antiviral.2017.07.007","article-title":"Structure-based discovery of clinically approved drugs as Zika virus NS2B-NS3 protease inhibitors that potently inhibit Zika virus infection in vitro and in vivo","volume":"145","author":"Yuan","year":"2017","journal-title":"Antiviral Res"},{"key":"10.1007\/s13311-017-0575-2_bib82","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.antiviral.2017.02.002","article-title":"Novel antiviral activity and mechanism of bromocriptine as a Zika virus NS2B-NS3 protease inhibitor","volume":"141","author":"Chan","year":"2017","journal-title":"Antiviral Res"},{"issue":"4","key":"10.1007\/s13311-017-0575-2_bib83","doi-asserted-by":"crossref","first-page":"197","DOI":"10.4103\/0253-7613.56070","article-title":"Bromocriptine mesylate: FDA-approved novel treatment for type-2 diabetes","volume":"41","author":"Mahajan","year":"2009","journal-title":"Indian J Pharmacol"},{"issue":"2","key":"10.1007\/s13311-017-0575-2_bib84","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1375\/twin.9.2.279","article-title":"Pregnancy outcome among twins conceived after subfertility treatment compared with natural twins: a population-based study","volume":"9","author":"Murphy","year":"2006","journal-title":"Twin Res Hum Genet"},{"key":"10.1007\/s13311-017-0575-2_bib85","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.antiviral.2017.04.015","article-title":"Characterization of the Zika virus two-component NS2B-NS3 protease and structure-assisted identification of allosteric small-molecule antagonists","volume":"143","author":"Shiryaev","year":"2017","journal-title":"Antiviral Res"},{"issue":"5","key":"10.1007\/s13311-017-0575-2_bib86","doi-asserted-by":"crossref","first-page":"e1006411","DOI":"10.1371\/journal.ppat.1006411","article-title":"A conformational switch high-throughput screening assay and allosteric inhibition of the flavivirus NS2B-NS3 protease","volume":"13","author":"Brecher","year":"2017","journal-title":"PLoS Pathog"},{"key":"10.1007\/s13311-017-0575-2_bib87","doi-asserted-by":"crossref","first-page":"13410","DOI":"10.1038\/ncomms13410","article-title":"Structure of the NS2B-NS3 protease from Zika virus after self-cleavage","volume":"7","author":"Phoo","year":"2016","journal-title":"Nat Commun"},{"key":"10.1007\/s13311-017-0575-2_bib88","doi-asserted-by":"crossref","DOI":"10.1126\/science.aai9309","article-title":"Crystal structure of unlinked NS2B-NS3 protease from Zika virus","author":"Zhang","year":"2016","journal-title":"Science"},{"key":"10.1007\/s13311-017-0575-2_bib89","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.antiviral.2017.03.011","article-title":"Solution conformations of a linked construct of the Zika virus NS2B-NS3 protease","volume":"142","author":"Mahawaththa","year":"2017","journal-title":"Antiviral Res"},{"key":"10.1007\/s13311-017-0575-2_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2017.03.108","article-title":"Increased activity of unlinked Zika virus NS2B\/NS3 protease compared to linked Zika virus protease","author":"Kuiper","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"10.1007\/s13311-017-0575-2_bib91","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s12250-013-3390-x","article-title":"The flavivirus protease as a target for drug discovery","volume":"28","author":"Brecher","year":"2013","journal-title":"Virol Sin"},{"key":"10.1007\/s13311-017-0575-2_bib92","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1038\/nbt1207-1379","article-title":"Hepatitis C: staying the course","volume":"25","author":"Garber","year":"2007","journal-title":"Nat Biotechnol"},{"issue":"20","key":"10.1007\/s13311-017-0575-2_bib93","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1056\/NEJMoa1214853","article-title":"Sofosbuvir for previously untreated chronic hepatitis C infection","volume":"368","author":"Lawitz","year":"2013","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1007\/s13311-017-0575-2_bib94","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1056\/NEJMoa1214854","article-title":"Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options","volume":"368","author":"Jacobson","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1007\/s13311-017-0575-2_bib95","article-title":"The clinically approved antiviral drug sofosbuvir impairs Brazilian zika virus replication","author":"Sacramento","year":"2016","journal-title":"bioRxiv"},{"key":"10.1007\/s13311-017-0575-2_bib96","doi-asserted-by":"crossref","first-page":"40920","DOI":"10.1038\/srep40920","article-title":"The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication","volume":"7","author":"Sacramento","year":"2017","journal-title":"Sci Rep"},{"issue":"10","key":"10.1007\/s13311-017-0575-2_bib97","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1016\/j.celrep.2016.08.038","article-title":"Zika virus disrupts phospho-TBK1 localization and mitosis in human neuroepithelial stem cells and radial glia","volume":"16","author":"Onorati","year":"2016","journal-title":"Cell Rep"},{"issue":"5","key":"10.1007\/s13311-017-0575-2_bib98","doi-asserted-by":"crossref","first-page":"e1002032","DOI":"10.1371\/journal.pmed.1002032","article-title":"Prices, costs, and affordability of new medicines for hepatitis C in 30 countries: an economic analysis","volume":"13","author":"Iyengar","year":"2016","journal-title":"PLOS Med"},{"issue":"3","key":"10.1007\/s13311-017-0575-2_bib99","doi-asserted-by":"crossref","first-page":"e01967","DOI":"10.1128\/AAC.01967-16","article-title":"Analysis of ribonucleotide 5\u2032-triphosphate analogs as potential inhibitors of Zika virus RNA-dependent RNA polymerase by using nonradioactive polymerase assays","volume":"61","author":"Lu","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1007\/s13311-017-0575-2_bib100","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.antiviral.2016.12.021","article-title":"Substrate selectivity of Dengue and Zika virus NS5 polymerase towards 2\u2032-modified nucleotide analogues","volume":"140","author":"Potisopon","year":"2017","journal-title":"Antiviral Res"},{"key":"10.1007\/s13311-017-0575-2_bib101","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.antiviral.2016.11.020","article-title":"Adenosine triphosphate analogs can efficiently inhibit the Zika virus RNA-dependent RNA polymerase","volume":"137","author":"Herc\u00edk","year":"2017","journal-title":"Antiviral Res"},{"issue":"5","key":"10.1007\/s13311-017-0575-2_bib102","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/infdis\/jiw226","article-title":"Nucleoside inhibitors of Zika virus","volume":"214","author":"Eyer","year":"2016","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1007\/s13311-017-0575-2_bib103","doi-asserted-by":"crossref","first-page":"e0004695","DOI":"10.1371\/journal.pntd.0004695","article-title":"The viral polymerase inhibitor 7-deaza-2'-C-methyladenosine is a potent inhibitor of in vitro Zika virus replication and delays disease progression in a robust mouse infection model","volume":"10","author":"Zmurko","year":"2016","journal-title":"PLOS Negl Trop Dis"},{"issue":"11","key":"10.1007\/s13311-017-0575-2_bib104","doi-asserted-by":"crossref","first-page":"e1003030","DOI":"10.1371\/journal.ppat.1003030","article-title":"Sensitivity of mitochondrial transcription and resistance of RNA polymerase II dependent nuclear transcription to antiviral ribonucleosides","volume":"8","author":"Arnold","year":"2012","journal-title":"PLOS Pathog"},{"issue":"7496","key":"10.1007\/s13311-017-0575-2_bib105","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nature13027","article-title":"Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430","volume":"508","author":"Warren","year":"2014","journal-title":"Nature"},{"issue":"3","key":"10.1007\/s13311-017-0575-2_bib106","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jiph.2016.04.002","article-title":"BCX4430\u2014a broad-spectrum antiviral adenosine nucleoside analog under development for the treatment of Ebola virus disease","volume":"9","author":"Taylor","year":"2016","journal-title":"J Infect Public Health"},{"key":"10.1007\/s13311-017-0575-2_bib107","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.antiviral.2016.11.003","article-title":"Efficacy of the broad-spectrum antiviral compound BCX4430 against Zika virus in cell culture and in a mouse model","volume":"137","author":"Julander","year":"2017","journal-title":"Antiviral Res"},{"issue":"48","key":"10.1007\/s13311-017-0575-2_bib108","doi-asserted-by":"crossref","first-page":"20435","DOI":"10.1073\/pnas.0907010106","article-title":"An adenosine nucleoside inhibitor of dengue virus","volume":"106","author":"Yin","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1007\/s13311-017-0575-2_bib109","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofw175","article-title":"Adenosine analog NITD008 is a potent inhibitor of Zika virus","volume":"3","author":"Deng","year":"2016","journal-title":"Open Forum Infectious Diseases"},{"key":"10.1007\/s13311-017-0575-2_bib110","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14764","article-title":"Crystal structure of Zika virus NS5 RNA-dependent RNA polymerase","volume":"8","author":"Godoy","year":"2017","journal-title":"Nat Commun"},{"issue":"3","key":"10.1007\/s13311-017-0575-2_bib111","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1107\/S2053230X17001601","article-title":"Crystal structure of full-length Zika virus NS5 protein reveals a conformation similar to Japanese encephalitis virus NS5","volume":"73","author":"Upadhyay","year":"2017","journal-title":"Acta Crystallogr Sect F Struct Biol Commun"},{"key":"10.1007\/s13311-017-0575-2_bib112","article-title":"The structure of Zika virus NS5 reveals a conserved domain conformation","volume":"8","author":"Wang","year":"2017","journal-title":"Nat Commun"},{"key":"10.1007\/s13311-017-0575-2_bib113","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14762","article-title":"Structure and function of the Zika virus full-length NS5 protein","volume":"8","author":"Zhao","year":"2017","journal-title":"Nat Commun"},{"issue":"6","key":"10.1007\/s13311-017-0575-2_bib114","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/wrna.1191","article-title":"Regulation of flavivirus RNA synthesis and capping","volume":"4","author":"Saeedi","year":"2013","journal-title":"Wiley Interdiscip Rev RNA"},{"issue":"1","key":"10.1007\/s13311-017-0575-2_bib115","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0968-0004(00)01734-5","article-title":"Unwinding the \u201cGordian knot\u201d of helicase action","volume":"26","author":"Soultanas","year":"2001","journal-title":"Trends Biochem Sci"},{"issue":"10","key":"10.1007\/s13311-017-0575-2_bib116","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nrd1853","article-title":"Viral and cellular RNA helicases as antiviral targets","volume":"4","author":"Kwong","year":"2005","journal-title":"Nat Rev Drug Discov"},{"issue":"8","key":"10.1007\/s13311-017-0575-2_bib117","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1007\/s13238-016-0293-2","article-title":"Structural basis of Zika virus helicase in recognizing its substrates","volume":"7","author":"Tian","year":"2016","journal-title":"Protein Cell"},{"issue":"6","key":"10.1007\/s13311-017-0575-2_bib118","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s13238-016-0275-4","article-title":"The crystal structure of Zika virus helicase: basis for antiviral drug design","volume":"7","author":"Tian","year":"2016","journal-title":"Protein Cell"},{"key":"10.1007\/s13311-017-0575-2_bib119","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/nsmb.3258","article-title":"Structure of the NS3 helicase from Zika virus","volume":"23","author":"Jain","year":"2016","journal-title":"Nat Struct Mol Biol"},{"key":"10.1007\/s13311-017-0575-2_bib120","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkw941","article-title":"Molecular mechanism of divalent-metal-induced activation of NS3 helicase and insights into Zika virus inhibitor design","author":"Cao","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1007\/s13311-017-0575-2_bib121","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.antiviral.2017.02.005","article-title":"Structural features of Zika virus non-structural proteins 3 and-5 and its individual domains in solution as well as insights into NS3 inhibition","volume":"141","author":"Saw","year":"2017","journal-title":"Antiviral Res"},{"issue":"5","key":"10.1007\/s13311-017-0575-2_bib122","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/bjh.12154","article-title":"A phase 2 study of SRT501 (resveratrol) with bortezomib for patients with relapsed and or refractory multiple myeloma","volume":"160","author":"Popat","year":"2013","journal-title":"Br J Haematol"},{"issue":"8","key":"10.1007\/s13311-017-0575-2_bib123","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1093\/jac\/dks147","article-title":"Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug","volume":"67","author":"Mastrangelo","year":"2012","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"10.1007\/s13311-017-0575-2_bib124","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1365-2885.2008.00971.x","article-title":"Pharmacokinetics of ivermectin after maternal or fetal intravenous administration in sheep","volume":"31","author":"P\u00e9rez","year":"2008","journal-title":"J Vet Pharmacol Ther"},{"key":"10.1007\/s13311-017-0575-2_bib125","first-page":"CD005547","article-title":"Effect of administration of antihelminthics for soil\u2010transmitted helminths during pregnancy","volume":"6","author":"Salam","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1007\/s13311-017-0575-2_bib126","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1128\/AAC.02251-12","article-title":"Novel benzoxazole inhibitor of dengue virus replication that targets the NS3 helicase","volume":"57","author":"Byrd","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1007\/s13311-017-0575-2_bib127","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1021\/id5000458","article-title":"Benzothiazole and pyrrolone flavivirus inhibitors targeting the viral helicase","volume":"1","author":"Sweeney","year":"2015","journal-title":"ACS Infect Dis"},{"key":"10.1007\/s13311-017-0575-2_bib128","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gks623","article-title":"Identification and analysis of hepatitis C virus NS3 helicase inhibitors using nucleic acid binding assays","author":"Mukherjee","year":"2012","journal-title":"Nucleic Acids Res"},{"issue":"23","key":"10.1007\/s13311-017-0575-2_bib129","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1001\/jama.2016.18189","article-title":"Effect of pritelivir compared with valacyclovir on genital HSV-2 shedding in patients with frequent recurrences: a randomized clinical trial","volume":"316","author":"Wald","year":"2016","journal-title":"JAMA"},{"issue":"3","key":"10.1007\/s13311-017-0575-2_bib130","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1056\/NEJMoa1301150","article-title":"Helicase\u2013primase inhibitor pritelivir for HSV-2 infection","volume":"370","author":"Wald","year":"2014","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1007\/s13311-017-0575-2_bib131","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1099\/vir.0.062208-0","article-title":"Flavivirus RNA methylation","volume":"95","author":"Dong","year":"2014","journal-title":"J Gen Virol"},{"key":"10.1007\/s13311-017-0575-2_bib132","doi-asserted-by":"crossref","first-page":"16212","DOI":"10.1021\/jacs.6b10399","article-title":"Structural insight into NS5 of Zika virus leading to the discovery of MTase inhibitors","volume":"138","author":"Stephen","year":"2016","journal-title":"J Am Chem Soc"},{"issue":"12","key":"10.1007\/s13311-017-0575-2_bib133","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1016\/j.celrep.2016.08.091","article-title":"Structures of NS5 methyltransferase from Zika virus","volume":"16","author":"Coloma","year":"2016","journal-title":"Cell Rep"},{"key":"10.1007\/s13311-017-0575-2_bib134","doi-asserted-by":"crossref","DOI":"10.15252\/embj.201696241","article-title":"The crystal structure of Zika virus NS5 reveals conserved drug targets","author":"Duan","year":"2017","journal-title":"EMBO J"},{"issue":"5","key":"10.1007\/s13311-017-0575-2_bib135","doi-asserted-by":"crossref","first-page":"e02202","DOI":"10.1128\/JVI.02202-16","article-title":"Zika virus methyltransferase: structure and functions for drug design perspectives","volume":"91","author":"Coutard","year":"2017","journal-title":"J Virol"},{"issue":"9","key":"10.1007\/s13311-017-0575-2_bib136","doi-asserted-by":"crossref","first-page":"14830","DOI":"10.18632\/oncotarget.14780","article-title":"The conformational changes of Zika virus methyltransferase upon converting SAM to SAH","volume":"8","author":"Zhou","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1007\/s13311-017-0575-2_bib137","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1128\/AAC.3.1.49","article-title":"A9145, a new adenine-containing antifungal antibiotic: fermentation","volume":"3","author":"Boeck","year":"1973","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1007\/s13311-017-0575-2_bib138","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1007\/s00705-017-3345-x","article-title":"Structural basis of Zika virus methyltransferase inhibition by sinefungin","volume":"162","author":"Hercik","year":"2017","journal-title":"Arch Virol"},{"key":"10.1007\/s13311-017-0575-2_bib139","article-title":"Structure of the NS5 methyltransferase from Zika virus and implications in inhibitor design","author":"Zhang","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"10.1007\/s13311-017-0575-2_bib140","doi-asserted-by":"crossref","first-page":"5622","DOI":"10.1021\/acs.jmedchem.5b01653","article-title":"The medicinal chemistry of dengue virus","volume":"59","author":"Behnam","year":"2016","journal-title":"J Med Chem"},{"issue":"1","key":"10.1007\/s13311-017-0575-2_bib141","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.antiviral.2008.01.004","article-title":"Molecular strategies to inhibit the replication of RNA viruses","volume":"78","author":"Leyssen","year":"2008","journal-title":"Antiviral Res"},{"issue":"3","key":"10.1007\/s13311-017-0575-2_bib142","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1634\/theoncologist.10-3-176","article-title":"FDA drug approval summary: azacitidine (5-azacytidine, VidazaTM) for injectable suspension","volume":"10","author":"Kaminskas","year":"2005","journal-title":"Oncologist"},{"issue":"5","key":"10.1007\/s13311-017-0575-2_bib143","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1634\/theoncologist.2012-0465","article-title":"Concise drug review: azacitidine and decitabine","volume":"18","author":"Derissen","year":"2013","journal-title":"Oncologist"},{"issue":"8","key":"10.1007\/s13311-017-0575-2_bib144","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: identifying and developing new uses for existing drugs","volume":"3","author":"Ashburn","year":"2004","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"10.1007\/s13311-017-0575-2_bib145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2009.10.002","article-title":"The development of antiretroviral therapy and its impact on the HIV-1\/AIDS pandemic","volume":"85","author":"Broder","year":"2010","journal-title":"Antiviral Res"},{"issue":"7","key":"10.1007\/s13311-017-0575-2_bib146","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1021\/jo01030a546","article-title":"Nucleosides. V. The monomesylates of 1-(2'-Deoxy-\u03b2-D-lyxofuranosyl) thymine1, 2","volume":"29","author":"Horwitz","year":"1964","journal-title":"J Org Chem"},{"issue":"3","key":"10.1007\/s13311-017-0575-2_bib147","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1073\/pnas.63.3.871","article-title":"The enzymatic termination of polydeoxynucleotides by 2\u2032, 3\u2032-dideoxyadenosine triphosphate","volume":"63","author":"Toji","year":"1969","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"10.1007\/s13311-017-0575-2_bib148","doi-asserted-by":"crossref","first-page":"4980","DOI":"10.1073\/pnas.71.12.4980","article-title":"Induction of endogenous virus and of thymidine kinase by bromodeoxyuridine in cell cultures transformed by Friend virus","volume":"71","author":"Ostertag","year":"1974","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"20","key":"10.1007\/s13311-017-0575-2_bib149","doi-asserted-by":"crossref","first-page":"7096","DOI":"10.1073\/pnas.82.20.7096","article-title":"3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III\/lymphadenopathy-associated virus in vitro","volume":"82","author":"Mitsuya","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8525","key":"10.1007\/s13311-017-0575-2_bib150","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0140-6736(87)91968-4","article-title":"Response of human-immunodeficiency-virus-associated neurological disease to 3'-azido-3'-deoxythymidine","volume":"329","author":"Yarchoan","year":"1987","journal-title":"Lancet"},{"issue":"9","key":"10.1007\/s13311-017-0575-2_bib151","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1056\/NEJM198702263160925","article-title":"Development of antiretroviral therapy for the acquired immunodeficiency syndrome and related disorders","volume":"316","author":"Yarchoan","year":"1987","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1007\/s13311-017-0575-2_bib152","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1128\/AAC.01741-10","article-title":"Pharmacokinetics of single-dose daptomycin in patients with suspected or confirmed neurological infections","volume":"55","author":"Kullar","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1007\/s13311-017-0575-2_bib153","doi-asserted-by":"crossref","first-page":"202","DOI":"10.2174\/1389557511209030202","article-title":"Daptomycin: a review of properties, clinical use, drug delivery and resistance","volume":"12","author":"Vilhena","year":"2012","journal-title":"Mini Rev Med Chem"},{"key":"10.1007\/s13311-017-0575-2_bib154","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.stem.2017.06.017","article-title":"High-content screening in hPSC-neural progenitors identifies drug candidates that inhibit Zika virus infection in fetal-like organoids and adult brain","volume":"21","author":"Zhou","year":"2017","journal-title":"Cell Stem Cell"},{"issue":"10","key":"10.1007\/s13311-017-0575-2_bib155","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nm.4184","article-title":"Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen","volume":"22","author":"Xu","year":"2016","journal-title":"Nat Med"},{"issue":"9","key":"10.1007\/s13311-017-0575-2_bib156","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/j.1365-2036.2010.04264.x","article-title":"Clinical trial: the efficacy and safety of oral PF\u201003491390, a pancaspase inhibitor: a randomized placebo-controlled study in patients with chronic hepatitis C","volume":"31","author":"Shiffman","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1007\/s13311-017-0575-2_bib157","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/nrd4504","article-title":"The history and future of targeting cyclin-dependent kinases in cancer therapy","volume":"14","author":"Asghar","year":"2015","journal-title":"Nat Rev Drug Discov"},{"issue":"9","key":"10.1007\/s13311-017-0575-2_bib158","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1124\/dmd.114.062745","article-title":"Brain exposure of two selective dual CDK4 and CDK6 inhibitors and the antitumor activity of CDK4 and CDK6 inhibition in combination with temozolomide in an intracranial glioblastoma xenograft","volume":"43","author":"Raub","year":"2015","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"10.1007\/s13311-017-0575-2_bib159","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJMoa1505270","article-title":"Palbociclib in hormone-receptor-positive advanced breast cancer","volume":"373","author":"Turner","year":"2015","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1007\/s13311-017-0575-2_bib160","doi-asserted-by":"crossref","first-page":"e78425","DOI":"10.1371\/journal.pone.0078425","article-title":"Identification of three antiviral inhibitors against Japanese encephalitis virus from library of pharmacologically active compounds 1280","volume":"8","author":"Fang","year":"2013","journal-title":"PLOS ONE"},{"issue":"10","key":"10.1007\/s13311-017-0575-2_bib161","doi-asserted-by":"crossref","first-page":"e1002976","DOI":"10.1371\/journal.ppat.1002976","article-title":"Niclosamide is a proton carrier and targets acidic endosomes with broad antiviral effects","volume":"8","author":"Jurgeit","year":"2012","journal-title":"PLOS Pathog"},{"issue":"4","key":"10.1007\/s13311-017-0575-2_bib162","doi-asserted-by":"crossref","first-page":"610","DOI":"10.4269\/ajtmh.1970.19.610","article-title":"Niclosamide treatment of cestodiasis. Clinical tirals in the United States","volume":"19","author":"Perera","year":"1970","journal-title":"Am J Trop Med Hyg"},{"key":"10.1007\/s13311-017-0575-2_bib163","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.antiviral.2016.11.018","article-title":"Evaluation of anti-Zika virus activities of broad-spectrum antivirals and NIH clinical collection compounds using a cell-based, high-throughput screen assay","volume":"138","author":"Adcock","year":"2017","journal-title":"Antiviral Res"},{"issue":"10","key":"10.1007\/s13311-017-0575-2_bib164","doi-asserted-by":"crossref","first-page":"e1003678","DOI":"10.1371\/journal.ppat.1003678","article-title":"Inhibition of pyrimidine biosynthesis pathway suppresses viral growth through innate immunity","volume":"9","author":"Lucas-Hourani","year":"2013","journal-title":"PLOS Pathog"},{"issue":"50","key":"10.1007\/s13311-017-0575-2_bib165","doi-asserted-by":"crossref","first-page":"14408","DOI":"10.1073\/pnas.1618029113","article-title":"Zika virus cell tropism in the developing human brain and inhibition by azithromycin","volume":"113","author":"Retallack","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1007\/s13311-017-0575-2_bib166","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-2393-6-18","article-title":"Pregnancy outcome following gestational exposure to azithromycin","volume":"6","author":"Sarkar","year":"2006","journal-title":"BMC Pregnancy Childbirth"},{"issue":"7","key":"10.1007\/s13311-017-0575-2_bib167","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1128\/AAC.01691-12","article-title":"Fetal safety of macrolides","volume":"57","author":"Dinur","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1007\/s13311-017-0575-2_bib168","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1067\/mob.2003.141","article-title":"Maternal and transplacental pharmacokinetics of azithromycin","volume":"188","author":"Ramsey","year":"2003","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1007\/s13311-017-0575-2_bib169","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1128\/AAC.40.3.825","article-title":"Distribution of azithromycin into brain tissue, cerebrospinal fluid, and aqueous humor of the eye","volume":"40","author":"Jaruratanasirikul","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1007\/s13311-017-0575-2_bib170","doi-asserted-by":"crossref","first-page":"34475","DOI":"10.1038\/srep34475","article-title":"Bithionol blocks pathogenicity of bacterial toxins, ricin, and Zika virus","volume":"6","author":"Leonardi","year":"2016","journal-title":"Sci Rep"},{"issue":"6","key":"10.1007\/s13311-017-0575-2_bib171","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/hep.1840140620","article-title":"Successful treatment of acute fascioliasis with bithionol","volume":"14","author":"Bacq","year":"1991","journal-title":"Hepatology"},{"issue":"6","key":"10.1007\/s13311-017-0575-2_bib172","first-page":"569","article-title":"Endemic paragonimiasis in Africa","volume":"50","author":"Nwokolo","year":"1974","journal-title":"Bull World Health Organ"},{"issue":"2","key":"10.1007\/s13311-017-0575-2_bib173","first-page":"135","article-title":"Fascioliasis: diagnosis, epidemiology and treatment","volume":"68","author":"Carrada-Bravo","year":"2002","journal-title":"Rev Gastroenterol Mex"},{"key":"10.1007\/s13311-017-0575-2_bib174","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0065-308X(10)73008-6","article-title":"The drugs we have and the drugs we need against major helminth infections","volume":"73","author":"Keiser","year":"2010","journal-title":"Adv Parasitol"},{"issue":"2","key":"10.1007\/s13311-017-0575-2_bib175","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1001\/archderm.1964.01600020021003","article-title":"Contact Photodermatitis from bithionol: II. Cross-sensitivities to hexachlorophene and salicylanilides","volume":"90","author":"Baughman","year":"1964","journal-title":"Arch Dermatol"},{"key":"10.1007\/s13311-017-0575-2_bib176","volume":"27","author":"Hartwig","year":"2013"},{"key":"10.1007\/s13311-017-0575-2_bib177","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.nbd.2014.08.017","article-title":"Novel therapeutic strategy for neurodegeneration by blocking A\u03b2 seeding mediated aggregation in models of Alzheimer's disease","volume":"74","author":"Eleuteri","year":"2015","journal-title":"Neurobiol Dis"},{"issue":"12","key":"10.1007\/s13311-017-0575-2_bib178","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3769\/radioisotopes.18.12_552","article-title":"Studies on the distribution of radioisotopes by whole body autoradiography (XIX)","volume":"18","author":"Takahashi","year":"1969","journal-title":"Radioisotopes"},{"key":"10.1007\/s13311-017-0575-2_bib179","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.antiviral.2016.11.015","article-title":"Antiviral activities of selected antimalarials against dengue virus type 2 and Zika virus","volume":"137","author":"Balasubramanian","year":"2017","journal-title":"Antiviral Res"},{"issue":"11","key":"10.1007\/s13311-017-0575-2_bib180","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/j.2042-7158.1997.tb06047.x","article-title":"Stereoselective passage of mefloquine through the blood\u2010brain barrier in the rat","volume":"49","author":"Baudry","year":"1997","journal-title":"J Pharm Pharmacol"},{"issue":"1","key":"10.1007\/s13311-017-0575-2_bib181","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1475-2875-13-75","article-title":"Mefloquine safety and tolerability in pregnancy: a systematic literature review","volume":"13","author":"Gonz\u00e1lez","year":"2014","journal-title":"Malar J"},{"key":"10.1007\/s13311-017-0575-2_bib182","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ejmech.2016.12.058","article-title":"2, 8-bis (trifluoromethyl) quinoline analogs show improved anti-Zika virus activity, compared to mefloquine","volume":"127","author":"Barbosa-Lima","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1007\/s13311-017-0575-2_bib183","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.ejmech.2017.01.007","article-title":"N-(2-(arylmethylimino) ethyl)-7-chloroquinolin-4-amine derivatives, synthesized by thermal and ultrasonic means, are endowed with anti-Zika virus activity","volume":"127","author":"Barbosa-Lima","year":"2017","journal-title":"Eur J Med Chem"},{"issue":"20","key":"10.1007\/s13311-017-0575-2_bib184","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1001\/archinte.1994.00420200116012","article-title":"Severe psychiatric side effects observed during prophylaxis and treatment with mefloquine","volume":"154","author":"Hennequin","year":"1994","journal-title":"Arch Intern Med"},{"key":"10.1007\/s13311-017-0575-2_bib185","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofx009","article-title":"Pediatric drug nitazoxanide: a potential choice for control of Zika","volume":"4","author":"Cao","year":"2017","journal-title":"Open Forum Infectious Diseases"},{"key":"10.1007\/s13311-017-0575-2_bib186","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.antiviral.2014.07.014","article-title":"Nitazoxanide: a first-in-class broad-spectrum antiviral agent","volume":"110","author":"Rossignol","year":"2014","journal-title":"Antiviral Res"},{"issue":"1","key":"10.1007\/s13311-017-0575-2_bib187","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1743-422X-11-10","article-title":"Nitazoxanide inhibits the replication of Japanese encephalitis virus in cultured cells and in a mouse model","volume":"11","author":"Shi","year":"2014","journal-title":"Virol J"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13311-017-0575-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-017-0575-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923014228?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923014228?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-017-0575-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:56:22Z","timestamp":1761807382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923014228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":187,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S1878747923014228"],"URL":"https:\/\/doi.org\/10.1007\/s13311-017-0575-2","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic Approaches for Zika Virus Infection of the Nervous System","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-017-0575-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2017 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}